| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO
1 company
Rothblatt Martine A is a Chairperson &CEO at UTHR. Recent filings cover 0 purchases and 462 sales. Those positions are worth an estimated $179.8M at current prices.
Our model assigns Rothblatt Martine A a middling insider score of 58/100, based on 304 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.6%.
Rothblatt Martine A's largest disclosed position is in UTHR as Chairperson &CEO, worth about $179.8M. The recent filings there lean toward selling, a net 347,599 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $499.03 | $4,740,795.40 | -2.8% | |
| Sep 4, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $489.20 | $4,647,354.42 | -2.8% | |
| Sep 3, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 6,466 | $486.49 | $3,145,647.60 | -2.0% | |
| Sep 2, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $493.46 | $4,687,841.30 | -2.8% | |
| Sep 1, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $514.09 | $4,883,839.34 | -2.8% | |
| Aug 31, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $511.09 | $4,855,312.39 | -2.8% | |
| Aug 28, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 5,948 | $519.00 | $3,087,032.99 | -1.8% | |
| Aug 27, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $522.57 | $4,964,375.66 | -2.8% | |
| Aug 26, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $517.28 | $4,914,189.61 | -2.8% | |
| Aug 25, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $517.71 | $4,918,273.18 | -2.8% |